An Indispensible Book on Disposables - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

An Indispensible Book on Disposables
Students and professionals can learn a good deal from a review of single-use technology.


Pharmaceutical Technology
Volume 35, Issue 5


Single-Use Technology in Biopharmaceutical Manufacture, Regine Eibl and Dieter Eibl, Eds., Wiley, Hoboken, NJ, 2011, 369 pp., ISBN: 9780470433515
The increasing demand on drug manufacturers to produce efficiently, reduce drug costs, and reduce time to market are several key reasons for the implementation of single-use systems. Single-Use Technology in Biopharmaceutical Manufacturing provides the reader with background information about this technology, and also describes advances in single-use products. The book helps guide the reader through the complex decision making process required for implementing disposable components.

The book's editors, Regine and Dieter Eibl, assembled an exceptionally diverse group of academic and industry experts to describe this increasingly popular technology. The text presents a solid technical and practical review of current single-use products and their applications in biopharmaceutical manufacturing. The preface defines the book's audience as individuals in advanced graduate studies in biopharmaceuticals, experienced end-users developing single-use systems, and professionals exploring disposable options in new or established process systems.

The book is divided into two major sections. The first section is devoted to current single-use products and offers expansive descriptions of technologies, including mixing and storage containers, complex bioreactor systems, and all the connecting disposable devices between. The second section delves into the components' practical applications using a case-study approach. Several of this section's chapters focus on comparable multiuse (i.e., stainless steel) systems and their associated costs.

The chapters are well written and, for the most part, easily readable for technical scientists and staff who do not have an engineering background. Although the discussion of each topic is brief, the authors present a reasonable amount of detail, thus giving the reader a comprehensive overview of each single-use technology or application. Each chapter provides a wealth of references for the reader interested in deep research into these topics.

The book's first section contains well-rounded discussions of disposable components, such as bags, sensors, filtration and separation devices, downstream processing equipment, connectors, fittings, tubing, and bioreactors. Each chapter details the core technology and describes the advantages and drawbacks one must consider in implementing single-use products.

The section's contributors are subject-matter experts who explain each product's scope. The authors also list various device manufacturers for each item and provide basic comparison tables to assist the reader in making informed choices. These tools should help the reader sort through the myriad of products to select and specify the appropriate system design for his or her application (e.g., upstream or downstream processing).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here